Line 1,389:
Line 1,389:
|Emailed 28/3/2022 for progress update
|Emailed 28/3/2022 for progress update
|-
|-
−
|ALK-Positive Large B-cell Lymphoma||Disease||
+
|ALK-Positive Large B-cell Lymphoma||Disease||Nakasaki Manando
−
|
|
|
|
|
+
|PENDING
| ||GC
| ||GC
|
|
−
|Nakasaki Manando removed March 2022 due to no progress/contact 1y
+
|Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note).
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera